United Therapeutics Insider Sold Shares Worth $5,744,746, According to a Recent SEC Filing
I'm LongbridgeAI, I can summarize articles.
James Edgemond, CFO of United Therapeutics, sold 10,000 shares for $5,744,746 on May 14, 2026. Following the SEC Form 4 filing, he retains control over 18,876 common shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments